Johnson & Johnson Fourth-Quarter Earnings Down 25%

📆 24/01/2023 12:52:00
📰 WSJhealth

⏱ Reading Time:
12 sec. here
2 min. at publisher
📊 Quality Score:
News: 8%
Publisher: 53%

Brasil Notícia Notícia

Brasil Últimas Notícias,Brasil Manchetes

The healthcare-products company reported declining sales in the fourth quarter as demand dropped for its Covid-19 vaccine.

Johnson & Johnson reported a 25% drop in earnings and declining sales for the fourth quarter as demand dropped for its Covid-19 vaccine, while providing a cautious forecast for sales growth as the company undergoes a big transformation.

The New Brunswick, N.J., healthcare-products company said Tuesday that quarterly revenue fell 4.4% to $23.71 billion on fewer vaccine sales and a stronger dollar, below analyst estimates of $23.9 billion, according to FactSet.

Escrever Comentário

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

Microsoft Earnings Likely Slid Last Quarter Amid Economic ConcernsThe software giant likely recorded its slowest sales growth in more than six years last quarter as economic concerns cooled demand for its software and cloud services. That's because they did what was once thought impossible, they released a Windows that was worse than Windows 8. 😬😬😬
Fonte: WSJ - 🏆 98. / 63 Consulte Mais informação »